Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

Results of Comprehensive SARS-CoV-2 Non-Human Primate Study Published

USAMRIID Scientists Engineer First Lethal Mouse Model for COVID-19

by Global Biodefense Staff August 27, 2020, 9:30 am
Thailand Begins Coronavirus Vaccine Trials on Monkeys

by Global Biodefense Staff May 23, 2020, 4:10 pm
‘Dirty Mice’ Could Help Make a More Effective Flu Vaccine

by Global Biodefense Staff May 12, 2020, 8:00 am
Investigational Chimp Adenovirus MERS-CoV Vaccine Protects Monkeys

by Global Biodefense Staff April 17, 2020, 3:00 am
Virus Shedding in Rhesus Macaques Innoculated with SARS-CoV-2

by Global Biodefense Staff March 22, 2020, 2:10 pm
Tulane National Primate Research Center Launches Coronavirus Research Program

by Global Biodefense Staff February 21, 2020, 11:52 am
Study Shows Virulence of B. pseudomallei Strain in Aerosol Model

by Global Biodefense Staff July 23, 2019, 9:00 am
Submit Your Suggestions for the NIAID Tuberculosis Strategic Framework

by Global Biodefense Staff July 5, 2018, 11:10 am
Crimean-Congo Hemorrhagic Fever: New NHP Model Developed

by Stephanie Lizotte April 22, 2018, 7:01 am
Medical Countermeasure Nonclinical Studies Network Contract Awards

by Global Biodefense Staff March 30, 2017, 9:00 am
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
Studying the Early Impact of Ebola Virus on the Immune System

by Global Biodefense Staff January 17, 2017, 11:13 am
RFI – Development of Animal Models for Antibacterial Drug Development

by Global Biodefense Staff January 5, 2017, 3:57 pm
NHLBI Updates Research Topics of Special Interest

by Global Biodefense Staff July 14, 2016, 11:56 am
U.S. Army Partners with Sanofi Pasteur to Develop Zika Vaccine

by Global Biodefense Staff July 6, 2016, 9:11 am

Congratulations. You've reached the end of the internet.

Animal Models

Results of Comprehensive SARS-CoV-2 Non-Human Primate Study Published

Stopping Lethal Lung Damage from Influenza: MG53 Protein Shows Promise in Animal Models

High Dose Favipiravir Countered SARS-CoV-2 in Hamsters, Hydroxychloroquine Ineffective

NIH Funds a $9.3M Center for Precision Animal Modeling at UAB

USAMRIID Scientists Engineer First Lethal Mouse Model for COVID-19

Thailand Begins Coronavirus Vaccine Trials on Monkeys

‘Dirty Mice’ Could Help Make a More Effective Flu Vaccine

Investigational Chimp Adenovirus MERS-CoV Vaccine Protects Monkeys

Virus Shedding in Rhesus Macaques Innoculated with SARS-CoV-2

Tulane National Primate Research Center Launches Coronavirus Research Program

Study Shows Virulence of B. pseudomallei Strain in Aerosol Model

Submit Your Suggestions for the NIAID Tuberculosis Strategic Framework

Crimean-Congo Hemorrhagic Fever: New NHP Model Developed

Medical Countermeasure Nonclinical Studies Network Contract Awards

Studying the Early Impact of Ebola Virus on the Immune System

RFI – Development of Animal Models for Antibacterial Drug Development

NHLBI Updates Research Topics of Special Interest

U.S. Army Partners with Sanofi Pasteur to Develop Zika Vaccine

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest stories

Latest Articles